-- 
China Stocks: Huaneng Power, Shenzhen Hepalink, Zijin Mining

-- B y   B l o o m b e r g   N e w s
-- 
2011-05-04T03:15:31Z

-- http://www.bloomberg.com/news/2011-05-03/camc-engineering-nanjing-port-vanke-china-equity-preview.html
The following companies had unusual
price changes in  China  trading. Stock symbols are in parentheses
and share prices are as of 10:48 a.m. local time.  The Shanghai Composite Index, which tracks the bigger of
China’s stock exchanges, fell 0.7 percent to 2,912.04. The  CSI
300 Index (SHSZ300)  dropped 0.7 percent to 3,188.37.  Port operators: Shanghai International Port Group Co.
(600018 CH), operator of China’s busiest harbor, advanced 1.2
percent to 4.20 yuan. Nanjing Port Co. (002040 CH) rose 1.6
percent to 8.90 yuan.  China will spend 18 billion yuan over the five years to
2015 to deepen the navigation channel of the  Yangtze River , the
official Xinhua News Agency reported, citing local authorities.
Upon completion, 50,000-ton vessels will be able to travel from
the sea to the eastern city of Nanjing.  Power producers:  Huaneng Power International Inc. (600011)  (600011
CH), the listed unit of China’s largest power group, jumped 1
percent to 6.40 yuan, set for its highest close since Nov. 11.
China Yangtze Power Co. (600900 CH) added 0.2 percent to 8.29
yuan.  The China Electricity Council has asked the government to
“appropriately” increase power prices to help ease supply
shortages, the Shanghai Securities News reported today. It
didn’t say if the increase was urged for retail or on-grid
prices.  China CAMC Engineering Co. (002051 CH) surged 5.2 percent
to 38.73 yuan, heading for its highest close since Feb. 21. The
state-owned company signed a contract worth 189 million euro
($281 million) to build a concentration plant in  Iran  which will
have an annual output of 4 million tons.  Shenzhen Hepalink Pharmaceutical Co. (002399 CH) slid 3
percent to 37.04 yuan, heading for the lowest close since its
listing on May 6. The company’s 90 million shares owned by GS
Direct Pharma Ltd. will become tradable on May 6, according to a
statement to Shenzhen’s stock exchange late yesterday. GS Direct
Pharma, a unit of Goldman Sachs Group Inc., paid $4.9 million
for 12.5 percent of Hepalink in 2007, according to Hepalink’s
share sale prospectus.  Xiamen Tungsten Co. (600549 CH) climbed 4.8 percent to
44.75 yuan, set for the biggest gain since March 16. The company
will set up a 2 billion yuan ($308 million) alloy processing
plant in Jiujiang, Jiangxi province, with China Minmetals
Nonferrous Metals Co., according to a Shanghai stock exchange
filing yesterday.  Zijin Mining Group Co. (601899 CH), China’s largest gold
producer, slipped 2.3 percent to 7.39 yuan. The company said an
appeals court in  Fujian province  upheld a criminal fine of 20.4
million yuan against the company for allowing waste water to
leak from the Zijinshan Gold & Copper Mine.  --Irene Shen,  Helen Sun . Editor: Allen Wan  To contact Bloomberg News staff for this story:
Irene Shen in Shanghai at +86-21-6104-3040 or
 Ishen4@bloomberg.net   To contact the editor responsible for this story:
Darren Boey at 
 dboey@bloomberg.net  